CoinW Exchange to List BIO Token, Advancing DeSci and Biotechnology Research
TL;DR
CoinW will list BIO, a DeSci project, on DeSci Zone, providing an opportunity for early adoption and potential profit.
BIO token powers the Bio Protocol ecosystem, governing voting, staking, trading, and funding allocation.
Bio Protocol aims to reshape biotechnology research funding, focusing on rare diseases, longevity, and health challenges for a better future.
CoinW's listing of BIO, a DeSci project, exemplifies the synergy of blockchain technology and scientific innovation, creating new opportunities in the crypto space.
Found this article helpful?
Share it with your network and spread the knowledge!

CoinW, a leading cryptocurrency trading platform, has announced the listing of BIO, the token powering the Bio Protocol project, on its DeSci Zone. Trading for the BIO/USDT pair will commence on January 3rd, 2024, at 10:00 UTC, marking a significant milestone for the decentralized science (DeSci) sector.
Bio Protocol, backed by major players including Binance and developed by the team behind VitaDAO, aims to transform biotechnology research funding, development, and intellectual property sharing through a decentralized autonomous organization (DAO) model. With total funding exceeding $33 million, the project focuses on critical areas such as rare diseases, longevity, and emerging health challenges.
The BIO token serves multiple functions within the Bio Protocol ecosystem, including governance, incentives through staking, liquidity provision, and direct funding allocation for research projects. With a total supply of 3.32 billion BIO, the token's economics are designed to support long-term ecosystem growth and reward community participation.
This listing on CoinW represents a significant step forward for the DeSci movement, potentially increasing accessibility and visibility for blockchain-based scientific research initiatives. It could lead to greater funding opportunities for traditionally underserved areas of biomedical research, potentially accelerating breakthroughs in critical health domains.
The integration of blockchain technology with scientific research, as exemplified by Bio Protocol, may pave the way for more transparent, efficient, and democratized research funding models. This could have far-reaching implications for the biotechnology industry, potentially disrupting traditional funding mechanisms and accelerating innovation in life sciences.
To celebrate the listing, CoinW is launching a 'BIO Bounty Program' with a reward pool of 10,000 USDT, encouraging user engagement and potentially boosting initial trading volume for the newly listed token. This event, running from the listing date until January 10th, 2024, at 16:00 UTC, may contribute to increased visibility and adoption of the BIO token and, by extension, the Bio Protocol project.
As the DeSci sector continues to evolve, the listing of BIO on a major exchange like CoinW could signal growing mainstream acceptance of blockchain-based scientific initiatives. This development may encourage more traditional scientific institutions and researchers to explore decentralized funding and collaboration models, potentially leading to a paradigm shift in how scientific research is funded and conducted globally.
Curated from BlockchainWire

